Amyris Revenue and Competitors
Estimated Revenue & Valuation
- Amyris's estimated annual revenue is currently $356.8M per year.
- Amyris received $30.0M in venture funding in October 2016.
- Amyris's estimated revenue per employee is $253,575
- Amyris's total funding is $1.8B.
- Amyris's current valuation is $1.5B. (January 2022)
Employee Data
- Amyris has 1407 Employees.
- Amyris grew their employee count by -21% last year.
Amyris's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Accounting Officer and Corporate Controller | Reveal Email/Phone |
2 | CEO, Rose Inc and Head Product Innovation | Reveal Email/Phone |
3 | Chief Compliance Officer (previously: VP, Head Compliance and Litigation) | Reveal Email/Phone |
4 | VP, Strategy and Business Development | Reveal Email/Phone |
5 | SVP Global Operations, Consumer Division | Reveal Email/Phone |
6 | Head Creative Studio | Reveal Email/Phone |
7 | VP Digital & Data | Reveal Email/Phone |
8 | VP Packaging Innovation & Sustainability | Reveal Email/Phone |
9 | Head Performance & risk management | Reveal Email/Phone |
10 | VP, Program Management, Circular Economy Ingredients | Reveal Email/Phone |
Amyris Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $19.6M | 130 | -56% | $974.1M | $562.2M |
#2 | $313.8M | 893 | 5% | N/A | N/A |
What Is Amyris?
Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise products and services across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.
keywords:Biotechnology,Cleantech,Food & Beverages,Healthcare,Household & Personal Products,Personal Products,Pharmaceuticals,Wind Power
$1.8B
Total Funding
1407
Number of Employees
$356.8M
Revenue (est)
-21%
Employee Growth %
$1.5B
Valuation
N/A
Accelerator
Amyris News
On average, analysts expect that Amyris will report full year earnings of ($0.73) per share for the current year, with EPS estimates ranging...
The greenfield site at Barra Bonita is a strategic investment with which Amyris leads the biotechnology sector with manufacturing at industrial...
EMERYVILLE, Calif., April 14, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the...
EMERYVILLE, Calif., Sept. 7, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that, on August 31, it closed the a ...
EMERYVILLE, Calif., Aug. 24, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it closed the acquisitions of ...
Other Companies in Emeryville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $599.2M | 2054 | 0% | $1000M |
#2 | $300M | 4505 | 3% | N/A |
Amyris Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2006-10-13 | $20.0M | A | Khosla Ventures | Article |
| 2007-09-20 | $70.0M | B | Duff Ackerman and Goodrich Ven | Article |
| 2008-08-15 | $21.0M | Undisclosed | Multiple | Article |
| 2009-08-24 | $24.8M | Third | Article | |
| 2009-10-02 | $41.8M | C | Article | |
| 2010-04-01 | $47.8M | Undisclosed | Temasek Holdings | Article |
| 2013-08-09 | $60.0M | Undisclosed | Temasek Life Science Ventures | Article |
| 2015-02-25 | $50.0M | Undisclosed | Nomis Bay Ltd | Article |
| 2015-10-15 | $50.0M | Undisclosed | Article | |
| 2016-10-07 | $30.0M | Undisclosed | Article |